Essa Pharma Inc Expected To Post A Loss Of 23 Cents A Share: Earnings Preview

ESSA Pharma

30/01/2023 12:43

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show no
change
in quarterly revenue when it reports  results on February 1
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for ESSA Pharma Inc is
for a
loss of 23 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $21​, above​ its last closing price of $2.80. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022              -0.27      -0.14     Beat    49.1
 Jun. 30 2022  -0.28       -0.27      -0.20     Beat    25.9
 Mar. 31 2022  -0.26       -0.25      -0.25     Met     1​
 Dec. 31 2021  -0.23       -0.23      -0.21     Beat    8.7
 ​​Sep.        -0.22       -0.23      -0.20     Beat    14
 30 2021                                                
 Jun. 30 2021  -0.26       -0.26      -0.21     Beat    20​
 Mar. 31 2021  -0.21       -0.21      -0.36     Missed  -68.2
 Dec. 31 2020  -0.17       -0.17      -0.20     Missed  -17.6
 This summary was machine generated January 30 at 12:43 GMT.  All
figures in US dollars  unless otherwise stated